Home HIV Medicine FAQ Unsubscribe Change Email Policy About Free Journals     

 
The Best Medical Websites:
Amedeo's Golden Links

  Irritable Bowel Syndrome, January 2002

Free Subscription


Abstracts

Retrieve all available abstracts of the following 412 articles:
HTML format


 

Single Articles

  1. SHAFIK A, El-Sibai O, Shafik AA, Ahmed I
    COLONIC PACING IN THE TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME: TECHNIQUE AND RESULTS.
    Front Biosci 2003; 8: B1-B5
    Abstract     Related articles   

  2. LINDQVIST S, Hernon J, Sharp P, Johns N, Addison S, Watson M et al
    The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.
    Br J Pharmacol 2002; 137: 1134-1142
    Abstract     Related articles   

  3. SABATE JM, Gorbatchef C, Flourie B, Jian R, Coffin B
    Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects.
    Neurogastroenterol Motil 2002; 14: 689-95
    Abstract     Related articles   

  4. HAUSER W, Grandt D
    [Psychophysiology of visceral pain syndromes]
    Schmerz 2002; 16: 460-6.
    Abstract     Related articles   

  5. GSCHOSSMANN JM, Holtmann G, Mayer EA
    [Epidemiology and clinical phenomenology of visceral pain]
    Schmerz 2002; 16: 447-51.
    Abstract     Related articles   

  6. HUNT RH, Tougas G
    Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.
    Best Pract Res Clin Gastroenterol 2002; 16: 869-83.
    Abstract     Related articles   

  7. DOUGHTY DB
    When Fiber is Not Enough: Current Thinking on Constipation Management.
    Ostomy Wound Manage 2002; 48: 30-41.
    Abstract     Related articles   

  8. CAMILLERI M
    Drugs targeting functional bowel disorders: lessons from drug trials.
    Curr Opin Pharmacol 2002; 2: 684-90.
    Abstract     Related articles   

  9. HICKS GA, Coldwell JR, Schindler M, Ward PA, Jenkins D, Lynn PA et al
    Excitation of rat colonic afferent fibres by 5-HT(3) receptors.
    J Physiol 2002; 544: 861-869
    Abstract     Related articles   

  10. REILLY BP, Bolton MP, Lewis MJ, Houghton LA, Whorwell PJ
    A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmography.
    Physiol Meas 2002; 23: 661-70
    Abstract     Related articles   

  11. STONES RW, Price C
    Health services for women with chronic pelvic pain.
    J R Soc Med 2002; 95: 531-5.
    Abstract     Related articles   

  12. KHAITAN L, Scholz S, Houston HL, Richards WO
    Results after laparoscopic lysis of adhesions and placement of seprafilm for intractable abdominal pain.
    Surg Endosc 2002; :
    Abstract     Related articles   

  13. LONGSTRETH GF, Drossman DA
    New developments in the diagnosis and treatment of irritable bowel syndrome.
    Curr Gastroenterol Rep 2002; 4: 427-34
    Abstract     Related articles   

  14. DANESHJOO R, J Talley N
    Eosinophilic gastroenteritis.
    Curr Gastroenterol Rep 2002; 4: 366-72
    Abstract     Related articles   

  15. SELLIN JH
    Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.
    Curr Gastroenterol Rep 2002; 4: 359-60
    Abstract     Related articles   

  16. HOLZER P
    Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain.
    Neurogastroenterol Motil 2002; 14: 459-75
    Abstract     Related articles   

  17. MESCHIA M, Buonaguidi A, Pifarotti P, Somigliana E, Spennacchio M, Amicarelli F
    Prevalence of anal incontinence in women with symptoms of urinary incontinence and genital prolapse.
    Obstet Gynecol 2002; 100: 719
    Abstract     Related articles   

  18. JONES BW, Moore DJ, Robinson SM, Song F
    A systematic review of tegaserod for the treatment of irritable bowel syndrome.
    J Clin Pharm Ther 2002; 27: 343-352
    Abstract     Related articles   

  19. FEE WH
    Irritable bowel syndrome helped by montelukast.
    Chest 2002; 122: 1497
    Abstract     Related articles   

  20. D’ANCHINO M, Orlo D, De Feudis L
    Giardia lamblia Infections become Clinically Evident by Eliciting Symptoms of Irritable Bowel Syndrome.
    J Infect 2002; 45: 169
    Abstract     Related articles   

  21. LOGAN AC, Beaulne TM
    The treatment of small intestinal bacterial overgrowth with enteric- coated peppermint oil: A case report.
    Altern Med Rev 2002; 7: 410-417
    Abstract     Related articles   

  22. ZAR S, Kumar D, Kumar D
    Role of blood hypersensitivity in irritable bowel syndrome.
    Minerva Med 2002; 93: 403-12
    Abstract     Related articles   

  23. HORWITZ BJ
    FDA OK’s two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tric
    Health News 2002; 8: 1-2
    Abstract     Related articles   


  24. Zelnorm: new treatment available for women with IBS.
    Nursing 2002; 32: 24, 26
    Abstract     Related articles   


  25. Tegaserod maleate (Zelnorm) for IBS with constipation.
    Med Lett Drugs Ther 2002; 44: 79-80
    Abstract     Related articles   

  26. DIOP L, Raymond F, Fargeau H, Petoux F, Chovet M, Doherty AM
    Pregabalin (CI-1008) Inhibits the Trinitrobenzene Sulfonic Acid-Induced Chronic Colonic Allodynia in the Rat.
    J Pharmacol Exp Ther 2002; 302: 1013-22
    Abstract     Related articles   

  27. WADE PR
    I. Age-related changes in the enteric nervous system.
    Am J Physiol Gastrointest Liver Physiol 2002; 283: G489-95
    Abstract     Related articles   

  28. GARCIA NOVO MF MD, Garcia Burriel JI, Pereda Perez A
    [Practical Guides to Nutrition (VII). Functional bowel disorders (equivalent to irritable bowel syndrome)]
    An Esp Pediatr 2002; 57: 253-63
    Abstract     Related articles   

  29. MARTEAU P, Marteau P, Seksik P, Jian R
    Probiotics and intestinal health effects: a clinical perspective.
    Br J Nutr 2002; 88 Suppl 1: S51-7
    Abstract     Related articles   

  30. HUNTER JO, Madden JA, Hunter JO
    A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
    Br J Nutr 2002; 88 Suppl 1: 67-72
    Abstract     Related articles   

  31. GIBSON GR, Fooks LJ, Gibson GR
    Probiotics as modulators of the gut flora.
    Br J Nutr 2002; 88 Suppl 1: 39-49
    Abstract     Related articles   

  32. HERR JR
    Medical literature implies continuous positive airway pressure might be appropriate treatment for irritable bowel syndrome.
    Chest 2002; 122: 1107
    Abstract     Related articles   

  33. GUSLANDI M, Fanti L, Testoni PA
    Helicobacter pylori seroprevalence in Crohn’s disease: lack of influence by pharmacological treatment.
    Hepatogastroenterology 2002; 49: 1296-7
    Abstract     Related articles   

  34. KOZMA CM, Barghout V, Slaton T, Frech F, Reeder CE
    A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.
    Manag Care Interface 2002; 15: 40-3, 49
    Abstract     Related articles   

  35. MOHAMED AE, Ghandour ZM, Al-Karawi MA
    Spasmocanulase in irritable bowel syndrome.
    Saudi Med J 2002; 23: 1074-7
    Abstract     Related articles   

  36. MULDER CJ, Hadithi MM, Rostami K, Goerres MS
    Coeliac disease - has the time come for routine mass screening ? In 2002 - 2010 - 2020 ?
    Rom J Gastroenterol 2002; 11: 179-82
    Abstract     Related articles   

  37. COLEMAN N, Spiller R
    No cause for alarm in IBS.
    Practitioner 2002; 246: 557
    Abstract     Related articles   

  38. BAZZOCCHI G, Gionchetti P, Almerigi PF, Amadini C, Campieri M
    Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.
    Dig Liver Dis 2002; 34 Suppl 2: S48-53
    Abstract     Related articles   

  39. GORBACH SL
    Probiotics in the third millennium.
    Dig Liver Dis 2002; 34 Suppl 2: S2-7
    Abstract     Related articles   

  40. MONERET-VAUTRIN DA
    [Food allergy diagnosis]
    Allerg Immunol (Paris) 2002; : 241-4.
    Abstract     Related articles   

  41. FARUP PG
    [Irritable bowel--an invention or dead seriousness?]
    Tidsskr Nor Laegeforen 2002; 122: 1919-20
    Abstract     Related articles   

  42. TJWA ET, Hadithi M, Goerres MS, Mulder ChJ
    [The Dutch College of General Practitioners’ ’Irritable bowel syndrome’ standard]
    Ned Tijdschr Geneeskd 2002; 146: 1516
    Abstract     Related articles   

  43. VAN DER HORST HE, Boukes FS, Assendelft WJ
    [The Dutch College of General Practitioners’ ’Irritable bowel syndrome’ standard]
    Ned Tijdschr Geneeskd 2002; 146: 1516-7
    Abstract     Related articles   


  44. Alosetron (lotronex) revisited.
    Med Lett Drugs Ther 2002; 44: 67-8
    Abstract     Related articles   

  45. SACH JA, Chang L
    Irritable Bowel Syndrome.
    Curr Treat Options Gastroenterol 2002; 5: 267-278
    Abstract     Related articles   

  46. QUIGLEY EM
    Aerophagia and Intestinal Gas.
    Curr Treat Options Gastroenterol 2002; 5: 259-265
    Abstract     Related articles   

  47. TORRENTS D, Torres R, De Mora F, Vergara P
    Antinerve Growth Factor Treatment Prevents Intestinal Dysmotility in Trichinella spiralis-Infected Rats.
    J Pharmacol Exp Ther 2002; 302: 659-65
    Abstract     Related articles   

  48. VERNE GN, Price DD
    Irritable bowel syndrome as a common precipitant of central sensitization.
    Curr Rheumatol Rep 2002; 4: 322-8
    Abstract     Related articles   

  49. MURRAY IA, Daniels I, Coupland K, Smith JA, Long RG
    Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease.
    Am J Physiol Gastrointest Liver Physiol 2002; 283: G319-26
    Abstract     Related articles   

  50. CORSETTI M, Tack J
    Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome.
    Expert Opin Pharmacother 2002; 3: 1211-8
    Abstract     Related articles   

  51. GIAQUINTA D
    Contemporary thoughts on the treatment of irritable bowel syndrome.
    Manag Care Interface 2002; 15: 19-20, 22
    Abstract     Related articles   

  52. SAND P, Rydqvist B
    The low conductance K(+) channel in human colonic crypt cells has a voltage-dependent permeability not affected by Mg(++).
    Life Sci 2002; 71: 855-64
    Abstract     Related articles   

  53. GALOVSKI TE, Blanchard EB
    Hypnotherapy and refractory irritable bowel syndrome: a single case study.
    Am J Clin Hypn 2002; 45: 31-7
    Abstract     Related articles   

  54. HEITKEMPER M, Jarrett M, Bond E
    Irritable bowel syndrome: More than a gut feeling.
    J Wound Ostomy Continence Nurs 2002; 29: 202-9
    Abstract     Related articles   


  55. Hypnotherapy effective for IBS.
    Health News 2002; 8: 7-8
    Abstract     Related articles   

  56. LAL S, Whorwell PJ
    What do patients with irritable bowel syndrome dream about? A comparison with inflammatory bowel disease.
    Dig Liver Dis 2002; 34: 506-9
    Abstract     Related articles   

  57. MOTZER SA, Jarrett M, Heitkemper MM, Tsuji J
    Natural killer cell function and psychological distress in women with and without irritable bowel syndrome.
    Biol Res Nurs 2002; 4: 31-42
    Abstract     Related articles   

  58. MONTALTO M, Arancio F, Izzi D, Cuoco L, Curigliano V, Manna R et al
    [In Process Citation]
    Ann Ital Med Int 2002; 17: 157-65
    Abstract     Related articles   

  59. GRAY GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM
    Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study.
    Am J Epidemiol 2002; 155: 1033-44
    Abstract     Related articles   

  60. LOPEZ-RODRIGUEZ ML, Benhamu B, Morcillo MJ, Murcia M, Viso A, Campillo M et al
    5-HT(4) Receptor Antagonists: Structure-Affinity Relationships and Ligand-Receptor Interactions.
    Curr Top Med Chem 2002; 2: 625-41
    Abstract     Related articles   

  61. MARTEAU PR
    Probiotics in clinical conditions.
    Clin Rev Allergy Immunol 2002; 22: 255-73
    Abstract     Related articles   

  62. STEENS J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA
    Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.
    Neurogastroenterol Motil 2002; 14: 241-7
    Abstract     Related articles   

  63. SCHIKOWSKI A, Thewissen M, Mathis C, Ross HG, Enck P
    Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum.
    Neurogastroenterol Motil 2002; 14: 221-7
    Abstract     Related articles   


  64. Can fruit juices cause irritable bowel syndrome?...and could they play a role in colic?
    Child Health Alert 2002; 20: 1-2
    Abstract     Related articles   

  65. BLANCHARD EB, Scharff L
    Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children.
    J Consult Clin Psychol 2002; 70: 725-38
    Abstract     Related articles   

  66. LEVY J
    Use of electrogastrography in children.
    Curr Gastroenterol Rep 2002; 4: 259-65
    Abstract     Related articles   

  67. SANDERS DS
    Coeliac disease.
    Br J Surg 2002; 89: 676-7
    Abstract     Related articles   

  68. DUFOUR JF, St-Pierre MV
    [In Process Citation]
    Ther Umsch 2002; 59: 313-6
    Abstract     Related articles   

  69. DOSH SA
    Evaluation and treatment of constipation.
    J Fam Pract 2002; 51: 555-9
    Abstract     Related articles   

  70. VEGA-BASULTO SD, Mosquera-Betancourt G, Varela Hernandez A
    [Ogilvie’s syndrome. A report of 3 cases]
    Neurocirugia (Astur) 2002; : 229-32
    Abstract     Related articles   

  71. MALT UF, Malt EA, Blomhoff S, Refnin I
    [In Process Citation]
    Tidsskr Nor Laegeforen 2002; 122: 1379-84
    Abstract     Related articles   

  72. PETRIG CH, Degen L
    [Abdominal pain of unknown origin with changed stool habits. Irritable bowel syndrome]
    Schweiz Rundsch Med Prax 2002; 91: 933-5
    Abstract     Related articles   

  73. MOUZAS I, Fragkiadakis N, Moschandreas J, Karachristos A, Skordilis P, Kouroumalis E et al
    Validation and results of a questionnaire for functional bowel disorders in out-patients.
    BMC Public Health 2002; 2: 8
    Abstract     Related articles   

  74. BLOMHOFF S, Diseth TH, Jacobsen MB, Vatn M
    [In Process Citation]
    Tidsskr Nor Laegeforen 2002; 122: 1213-7
    Abstract     Related articles   

  75. WALDUM HL
    [Functional gastrointestinal diseases]
    Tidsskr Nor Laegeforen 2002; 122: 1178
    Abstract     Related articles   

  76. LANGMEAD L, Chitnis M, Rampton DS
    Use of complementary therapies by patients with IBD may indicate psychosocial distress.
    Inflamm Bowel Dis 2002; 8: 174-9
    Abstract     Related articles   

  77. ROMANS S, Belaise C, Martin J, Morris E, Raffi A
    Childhood Abuse and Later Medical Disorders in Women. an epidemiological study.
    Psychother Psychosom 2002; 71: 141-50
    Abstract     Related articles   

  78. PERSIANI S, Damato M, Makovec F, Tavares IA, Bishai PM, Rovati LC
    Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Int J Clin Pharmacol Ther 2002; 40: 198-206
    Abstract     Related articles   

  79. KANE S
    Gender issues in the management of inflammatory bowel disease and irritable bowel syndrome.
    Int J Fertil Womens Med 2002; 47: 136-42
    Abstract     Related articles   

  80. CHIAL HJ, Camilleri M
    Gender differences in irritable bowel syndrome.
    J Gend Specif Med 2002; 5: 37-45
    Abstract     Related articles   

  81. SPATH M
    Current experience with 5-HT3 receptor antagonists in fibromyalgia.
    Rheum Dis Clin North Am 2002; 28: 319-28
    Abstract     Related articles   

  82. GRASSI M, Lucchetta MC, Grossi F, Raffa S
    [In Process Citation]
    Clin Ter 2002; 153: 195-206
    Abstract     Related articles   

  83. REY E, Diaz-Rubio M
    Prevalence of rectal hypersensitivity in patients with irritable bowel syndrome and its clinical subgroups.
    Rev Esp Enferm Dig 2002; 94: 247-58.
    Abstract     Related articles   

  84. MEARIN F
    Assessing rectal sensitivity in irritable bowel syndrome: a positive diagnosis at last?
    Rev Esp Enferm Dig 2002; 94: 243-6.
    Abstract     Related articles   

  85. BOUKES FS, van der Horst HE, Assendelft WJ
    [In Process Citation]
    Ned Tijdschr Geneeskd 2002; 146: 799-802
    Abstract     Related articles   

  86. KLEIBEUKER JH
    [In Process Citation]
    Ned Tijdschr Geneeskd 2002; 146: 790-1
    Abstract     Related articles   

  87. MAZEL JA
    [In Process Citation]
    Ned Tijdschr Geneeskd 2002; 146: 789
    Abstract     Related articles   

  88. PANGANAMAMULA KV, Fisher RS, Parkman HP
    Functional (Nonulcer) Dyspepsia.
    Curr Treat Options Gastroenterol 2002; 5: 153-160
    Abstract     Related articles   

  89. MOUKARZEL AA, Lesicka H, Ament ME
    Irritable bowel syndrome and nonspecific diarrhea in infancy and childhood--relationship with juice carbohydrate malabsorption.
    Clin Pediatr (Phila) 2002; : 145-50
    Abstract     Related articles   

  90. HUGHES AJ, Ferguson I, Rankin E, Kane K
    Polymyositis as a cause of total gut failure.
    Ann Rheum Dis 2002; 61: 305-6
    Abstract     Related articles   

  91. FRANK L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C
    Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases.
    Clin Ther 2002; 24: 675-89
    Abstract     Related articles   

  92. WALKER LS, Sorrells SC
    Brief report: Assessment of children’s gastrointestinal symptoms for clinical trials.
    J Pediatr Psychol 2002; 27: 303-7
    Abstract     Related articles   

  93. CURIOSO WH, Donaires Mendoza N, Bacilio Zerpa C, Ganoza Gallardo C, Leon Barua R
    [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the peruvian jungle]
    Rev Gastroenterol Peru 2002; 22: 129-40
    Abstract     Related articles   

  94. BUSSALLEU RIVERA A DR A
    [Irritable bowel syndrome]
    Rev Gastroenterol Peru 2002; 22: 115-7
    Abstract     Related articles   

  95. LECCI A, Valenti C, Maggi CA
    Tachykinin receptor antagonists in irritable bowel syndrome.
    Curr Opin Investig Drugs 2002; 3: 589-601
    Abstract     Related articles   

  96. BUJANDA L, Gutierrez-Stampa MA, Caballeros CH, Alkiza ME
    [In Process Citation]
    An Med Interna 2002; 19: 179-82
    Abstract     Related articles   

  97. REY E, Alvarez Sanchez A, Diaz-Rubio M
    Which is the best distension protocol to study rectal sensitivity in the irritable bowel syndrome?
    Rev Esp Enferm Dig 2002; 94: 211-20
    Abstract     Related articles   

  98. SULE AZ, Uba AF, Kidmas AT
    Acute colonic pseudo-obstruction (Ogilvie’s syndrome). A case presentation and review of literature.
    Niger J Med 2002; 11: 56-9
    Abstract     Related articles   

  99. GROOFF B
    [Irritable bowel syndrome: pathophysiology and (future) treatment options]
    Ned Tijdschr Geneeskd 2002; 146: 540
    Abstract     Related articles   

  100. YANG C, Takahashi O, Goto M, Ohnishi M, Koyama H, Noguchi Y et al
    [Pseudoaneurysm of the thoracoabdominal aorta from colonic injury by the anterior fixation device]
    Nippon Naika Gakkai Zasshi 2002; 91: 1025-7
    Abstract     Related articles   

  101. BORMAN RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL et al
    5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro.
    Br J Pharmacol 2002; 135: 1144-51
    Abstract     Related articles   

  102. RU?HMANN A, Chapman J, Higelin J, Butscha B, Dautzenberg FM
    Design, synthesis and pharmacological characterization of new highly selective CRF(2) antagonists: development of 123I-K31440 as a potential SPECT ligand.
    Peptides 2002; 23: 453-460
    Abstract     Related articles   

  103. OKANO S, Ikeura Y, Inatomi N
    Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits.
    J Pharmacol Exp Ther 2002; 300: 925-31
    Abstract     Related articles   

  104. FRIC P
    [Probiotika in der gastroenterologie]
    Z Gastroenterol 2002; 40: 197-201
    Abstract     Related articles   

  105. ICKS A, Haastert B, Enck P, Rathmann W, Giani G
    Pravalenz von funktionellen Magen- Darmbeschwerden und damit verbundener Inanspruchnahme medizinischer Versorgung: eine populationsbasierte Untersuchung.
    Z Gastroenterol 2002; 40: 177-83
    Abstract     Related articles   

  106. IWANAGA Y
    [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)]
    Nippon Yakurigaku Zasshi 2002; 119: 185-90
    Abstract     Related articles   

  107. WANG W, Pan G, Qian J
    [Cognitive therapy for patients with refractory irritable bowel syndrome]
    Zhonghua Nei Ke Za Zhi 2002; 41: 156-9
    Abstract     Related articles   

  108. WANG W, Pan G, Qian J
    [Effect of psychological factors on visceral sensation of patients with irritable bowel syndrome]
    Zhonghua Yi Xue Za Zhi 2002; 82: 308-11
    Abstract     Related articles   


  109. The genetics of lactose intolerance.
    Harv Womens Health Watch 2002; 9: 6
    Abstract     Related articles   

  110. YUNUS MB
    Gender differences in fibromyalgia and other related syndromes.
    J Gend Specif Med 2002; 5: 42-7
    Abstract     Related articles   

  111. WILKINSON M
    Reflexology and irritable bowel syndrome.
    Br J Gen Pract 2002; 52: 238
    Abstract     Related articles   

  112. BOUGOUMA A, Drabo YJ, Serme AK, Zoungrana SL, Sombie AR, Ilboudo PD et al
    [Analysis of the results of 1221 colonoscopies in the hospitals of Burkina Faso, 1994-1997]
    Bull Soc Pathol Exot 2002; 95: 50-2
    Abstract     Related articles   

  113. HOEY J
    Irritable bowel syndrome: could it be celiac disease?
    CMAJ 2002; 166: 479-80
    Abstract     Related articles   

  114. WALDUM HL
    [Drug therapy of irritable bowel syndrome]
    Tidsskr Nor Laegeforen 2002; 122: 401-2
    Abstract     Related articles   

  115. COUTINHO SV, Plotsky PM, Sablad M, Miller JC, Zhou H, Bayati AI et al
    Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat.
    Am J Physiol Gastrointest Liver Physiol 2002; 282: G307-16
    Abstract     Related articles   

  116. ZEITER DK, Hyams JS
    Recurrent abdominal pain in children.
    Pediatr Clin North Am 2002; 49: 53-71
    Abstract     Related articles   

  117. BIRRER RB
    Irritable bowel syndrome.
    Dis Mon 2002; 48: 105-43
    Abstract     Related articles   

  118. BRADESI S, Eutamene H, Garcia-Villar R, Fioramonti J, Bueno L
    Acute and chronic stress differently affect visceral sensitivity to rectal distension in female rats.
    Neurogastroenterol Motil 2002; 14: 75-82
    Abstract     Related articles   

  119. WANG L, Fang X, Pan G
    [Intestinal infection and irritable bowel syndrome]
    Zhonghua Nei Ke Za Zhi 2002; 41: 90-3
    Abstract     Related articles   

  120. BENNETT G, Talley NJ
    Irritable bowel syndrome in the elderly.
    Best Pract Res Clin Gastroenterol 2002; 16: 63-76
    Abstract     Related articles   

  121. PALMA R
    [The patient with refractory functional disorders of the gastrointestinal tract]
    Rev Med Chil 2002; 130: 219-25
    Abstract     Related articles   

  122. SVEDLUND J
    [In Process Citation]
    Lakartidningen 2002; 99: 172-4
    Abstract     Related articles   

  123. DE SCHRYVER AM, Samsom M
    [In Process Citation]
    Ned Tijdschr Geneeskd 2002; 146: 12-7
    Abstract     Related articles   

  124. TOVEY P
    A single-blind trial of reflexology for irritable bowel syndrome.
    Br J Gen Pract 2002; 52: 19-23
    Abstract     Related articles   

  125. BEGLINGER C
    Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.
    Int J Clin Pract 2002; 56: 47-51
    Abstract     Related articles   

  126. FUKUDO S
    [Epidemiological data of irritable bowel syndrome]
    Nippon Rinsho 2002; 60 Suppl 1: 179-85
    Abstract     Related articles   

  127. THORN M, Graf W, Stefansson T, Pahlman L
    Clinical and functional results after elective colonic resection in 75 consecutive patients with diverticular disease.
    Am J Surg 2002; 183: 7-11
    Abstract     Related articles   

  128. KOUNTOURAS J, Chatzopoulos D, Zavos Ch, Boura P, Venizelos J, Kalis A
    Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Hepatogastroenterology 2002; 49: 193-7
    Abstract     Related articles   

  129. GRIGA T, May B, Pfisterer O, Muller KM, Brasch F
    Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Hepatogastroenterology 2002; 49: 116-23
    Abstract     Related articles   

  130. HUERTA C, Garcia Rodriguez LA, Wallander MA, Johansson S
    Risk of irritable bowel syndrome among asthma patients.
    Pharmacoepidemiol Drug Saf 2002; 11: 31-5
    Abstract     Related articles   

  131. BUJANDA L, Gutierrez-Stampa MA, Caballeros CH, Alkiza ME
    [In Process Citation]
    An Med Interna 2002; 19: 3-6
    Abstract     Related articles   

  132. VAN DEN DRIESSCHE M, Veereman-Wauters G
    Functional foods in pediatrics.
    Acta Gastroenterol Belg 2002; 65: 45-51
    Abstract     Related articles   

  133. CHERNOGOROVA MV, Belousova EA, Zlatkina AR, Komarova MV
    [Outpatient treatment of irritable colon syndrome: quality of diagnosis and treatment]
    Klin Med (Mosk) 2002; : 51-4
    Abstract     Related articles   

  134. GURLEYIK G, Kotan C, Dulundu E, Ozturk E, Sonmez R, Saglam A
    [Clinical differences between surgically treated patients with large bowel obstruction in the cities of Van and Istanbul]
    Ulus Travma Derg 2002; 8: 38-42
    Abstract     Related articles   

  135. GABRY KE, Chrousos GP, Rice KC, Mostafa RM, Sternberg E, Negrao AB et al
    Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.
    Mol Psychiatry 2002; 7: 474-83
    Abstract     Related articles   

  136. AKEHURST RL, Brazier JE, Mathers N, O’Keefe C, Kaltenthaler E, Morgan A et al
    Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting.
    Pharmacoeconomics 2002; 20: 455-62
    Abstract     Related articles   

  137. ALARADI O, Barkin JS
    Irritable bowel syndrome: update on pathogenesis and management.
    Med Princ Pract 2002; 11: 2-17
    Abstract     Related articles   

  138. RUBIO MA
    [In Process Citation]
    Nutr Hosp 2002; 17 Suppl 2: 17-29
    Abstract     Related articles   

  139. LEIBBRAND R, Cuntz U, Hiller W
    Assessment of functional gastrointestinal disorders using the Gastro- Questionnaire.
    Int J Behav Med 2002; 9: 155-72
    Abstract     Related articles   

  140. BADIA X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M et al
    Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria.
    Pharmacoeconomics 2002; 20: 749-58
    Abstract     Related articles   

  141. FRISSORA CL
    A new look at irritable bowel syndrome [IBS]: a neuroenteric disorder.
    Compr Ther 2002; 28: 222-31
    Abstract     Related articles   

  142. MARTINEZ-LAVIN M, Arechiga H, Schmulson M, Hermosillo AG
    [Frequent clinical syndromes without anatomical bases. New perspectives on fibromyalgia and irritable intestine]
    Gac Med Mex 2002; 138: 41-56
    Abstract     Related articles   

  143. APPEL-DINGEMANSE S
    Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT(4) Receptor Partial Agonist with Promotile Activity.
    Clin Pharmacokinet 2002; 41: 1021-42
    Abstract     Related articles   

  144. GORAL V, Uyar A, Muftuoglu E
    Ogilvie’s syndrome in patient with multiple myeloma.
    Dig Liver Dis 2002; 34: 85
    Abstract     Related articles   

  145. PARFENOV AI, Tkachenko EI
    [Irritable bowel syndrome]
    Eksp Klin Gastroenterol 2002; : 106-8, 122
    Abstract     Related articles   

  146. MINUSHKIN ON
    [Meteospazmil and its place in treating patients with irritable bowel syndrome]
    Eksp Klin Gastroenterol 2002; : 94-7
    Abstract     Related articles   

  147. ZHUKOV NA, Sorokina EA, Akhmedov VA
    [Role of endogenous humoral regulators of the intestines in formation of irritable bowel syndrome]
    Eksp Klin Gastroenterol 2002; : 86-90
    Abstract     Related articles   

  148. ONESCHUK D
    Colonic pseudo-obstruction in a patient with advanced small cell carcinoma.
    J Palliat Care 2002; 18: 202-4.
    Abstract     Related articles   

  149. REYNOLDS HY
    Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease.
    Lung 2002; 180: 281-99.
    Abstract     Related articles   

  150. FOXX-ORENSTEIN AE, Clarida JC
    Irritable bowel syndrome in women: the physician-patient relationship evolving.
    J Am Osteopath Assoc 2001; 101: S12-6
    Abstract     Related articles   

  151. CHELIMSKY G, Chelimsky T
    Familial association of autonomic and gastrointestinal symptoms.
    Clin Auton Res 2001; 11: 383-6
    Abstract     Related articles   

  152. SJOBLOM M, Flemstrom G
    Central nervous stimuli increase duodenal bicarbonate secretion by release of mucosal melatonin.
    J Physiol Pharmacol 2001; 52: 671-8
    Abstract     Related articles   

  153. HOLZER P, Michl T, Danzer M, Jocic M, Schicho R, Lippe IT
    Surveillance of the gastrointestinal mucosa by sensory neurons.
    J Physiol Pharmacol 2001; 52: 505-21
    Abstract     Related articles   

  154. GELBAYA TA, El-Halwagy HE
    Focus on primary care: chronic pelvic pain in women.
    Obstet Gynecol Surv 2001; 56: 757-64
    Abstract     Related articles   

  155. MA H, Chen Y, Liu Y
    [An epidemiological study on the risk factors of irritable bowel syndrome in Zhanjiang, Guangdong province]
    Zhonghua Liu Xing Bing Xue Za Zhi 2001; 22: 452-4
    Abstract     Related articles   

  156. PETRISOR BA, Petruccelli DT, Winemaker MJ, de Beer JV
    Acute colonic pseudo-obstruction after elective total joint arthroplasty.
    J Arthroplasty 2001; 16: 1043-7
    Abstract     Related articles   

  157. HOLZER P, Holzer-Petsche U
    Tachykinin receptors in the gut: physiological and pathological implications.
    Curr Opin Pharmacol 2001; 1: 583-90
    Abstract     Related articles   

  158. CAKIR E, Baykal S, Usul H, Kuzeyli K, Cinel A
    Ogilvie’s syndrome after cervical discectomy.
    Clin Neurol Neurosurg 2001; 103: 232-3
    Abstract     Related articles   

  159. CHEN HH HH, McCutcheon H
    Learning needs of Taiwanese nurses caring for patients with irritable bowel syndrome.
    Nurs Health Sci 2001; 3: 173-7
    Abstract     Related articles   

  160. MARTIN MJ, Steele SR, Noel JM, Weichmann D, Azarow KS
    Total colonic manometry as a guide for surgical management of functional colonic obstruction: Preliminary results.
    J Pediatr Surg 2001; 36: 1757-63
    Abstract     Related articles   

  161. BENLLOCH S, Perez-Aguilar F, Ponce J, Berenguer J
    [Chronic colonic pseudo-obstruction secondary to neuroleptics]
    Gastroenterol Hepatol 2001; 24: 500-2
    Abstract     Related articles   

  162. FELDMAN R
    [Probable amanita phalloides poisoning with pseudo-obstructive, paralytic ileus (Ogilvie’s syndrome)]
    Pol Arch Med Wewn 2001; 106: 1169-73
    Abstract     Related articles   

  163. STIEFELHAGEN P
    [Diets in irritable bowel syndrome--what do they really achieve? Please no culinary sadism!]
    MMW Fortschr Med 2001; 143: 18
    Abstract     Related articles   

  164. CSEF H
    [Functional (somatoform) disorders in house calls by internists]
    Internist (Berl) 2001; : 1476, 1480-2, 1485-7
    Abstract     Related articles   

  165. GONCALVES NS, Ghaem-Maghami M, Monteleone G, Frankel G, Dougan G, Lewis DJ et al
    Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.
    Infect Immun 2001; 69: 6651-9
    Abstract     Related articles   

  166. FOCK KM, Chew CN, Tay LK, Peh LH, Chan S, Pang EP
    Psychiatric illness, personality traits and the irritable bowel syndrome.
    Ann Acad Med Singapore 2001; 30: 611-4
    Abstract     Related articles   

  167. HOLZER P
    Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain.
    Eur J Pharmacol 2001; 429: 177-93
    Abstract     Related articles   

  168. GARCIA ISLAS P, Bustos Fernandez D
    [In Process Citation]
    Acta Gastroenterol Latinoam 2001; 31: 339-50
    Abstract     Related articles   

  169. BRECCIA M, Girmenia C, Mecarocci S, Cartoni C, Carmosino I, Tafuri A et al
    Ogilvie’s syndrome in acute myeloid leukemia: pharmacological approach with neostigmine.
    Ann Hematol 2001; 80: 614-6
    Abstract     Related articles   

  170. EVANGELISTA S
    Eziopitant. Pfizer.
    Curr Opin Investig Drugs 2001; 2: 1441-3
    Abstract     Related articles   

  171. FURNESS J B
    TAK-637. Takeda.
    Curr Opin Investig Drugs 2001; 2: 1437-40
    Abstract     Related articles   

  172. STACHER G
    Cilansetron. Solvay.
    Curr Opin Investig Drugs 2001; 2: 1432-6
    Abstract     Related articles   

  173. RANA SV, Mandal AK, Kochhar R, Katyal R, Singh K
    Lactose intolerance in different types of irritable bowel syndrome in north Indians.
    Trop Gastroenterol 2001; 22: 202-4
    Abstract     Related articles   

  174. CAMPOS HURTADO G, Villareal Menchola J, Cornejo Zapata C, Leon Barua R
    [Prevalence of Manning’s symptoms in a Lima upper socioeconomic level population]
    Rev Gastroenterol Peru 2001; 21: 301-5
    Abstract     Related articles   

  175. MADISCH A, Hotz J
    [Symptomatic therapy of irritable bowel syndrome. Which drug for which symptoms?]
    MMW Fortschr Med 2001; 143: 28-30
    Abstract     Related articles   

  176. HOLZER P, Schicho R, Holzer-Petsche U, Lippe IT
    The gut as a neurological organ.
    Wien Klin Wochenschr 2001; 113: 647-60
    Abstract     Related articles   

  177. KELLOW JE
    Pathophysiology and management of irritable bowel syndrome.
    Korean J Intern Med 2001; 16: 137-46
    Abstract     Related articles   

  178. BENSOUSSAN A
    Establishing evidence for Chinese medicine: a case example of irritable bowel syndrome.
    Zhonghua Yi Xue Za Zhi (Taipei) 2001; : 487-92
    Abstract     Related articles   

  179. SCRIMGEOUR D
    Chronic intermittent diarrhoea and fatigue.
    Aust Fam Physician 2001; 30: 897
    Abstract     Related articles   


  180. [In Process Citation]
    Lik Sprava 2001; : 168-71
    Abstract     Related articles   


  181. [In Process Citation]
    Lik Sprava 2001; : 166-8
    Abstract     Related articles   

  182. HAROUNA YD, Seibou A, Ganda S, Bazira L
    [Colonic pseudo-obstruction disclosing bladder calculi: report of 2 cases]
    Prog Urol 2001; 11: 700-2
    Abstract     Related articles   

  183. WISE TN, Sheridan MJ
    Psychometric properties of the Illness Attitudes Scale in psychiatric patients.
    Psychol Rep 2001; 89: 73-6
    Abstract     Related articles   

  184. KENDALL-TACKETT K
    Chronic pain: the next frontier in child maltreatment research.
    Child Abuse Negl 2001; 25: 997-1000
    Abstract     Related articles   

  185. TIBBLE J, Bjarnason I
    Non-invasive investigation of inflammatory bowel disease.
    World J Gastroenterol 2001; 7: 460-5
    Abstract     Related articles   

  186. KESHAVARZIAN A, Bruninga K, Fields J, Farhadi A
    Irritable bowel syndrome: an update on therapeutic modalities.
    Expert Opin Investig Drugs 2001; 10: 1211-1222
    Abstract     Related articles   

  187. AHLUWALIA A
    Nepadutant Menarini Richerche.
    Curr Opin Investig Drugs 2001; 2: 919-22
    Abstract     Related articles   

  188. DELVAUX MM
    Visceral sensitivity in explaining functional bowel disorders: from concepts to clinical practice.
    Acta Gastroenterol Belg 2001; 64: 272-5
    Abstract     Related articles   

  189. CAMPOS HURTADO G, Leon Barua R, Villareal Menchola J, Berendson Seminario R, Cornejo Zapata C
    [Association between irritable intestinal syndrome and depressive symptoms in a population of high socioeconomical level of Lima]
    Rev Gastroenterol Peru 2001; 21: 198-204
    Abstract     Related articles   

  190. FREEMAN SL, Boswell JC, Smith RK
    Use of transrectal ultrasonography to aid diagnosis of small colon strangulation in two horses.
    Vet Rec 2001; 148: 812-3
    Abstract     Related articles   

  191. BANERJEE S, Farrell RJ, Lembo T
    Gastroenterological causes of pelvic pain.
    World J Urol 2001; 19: 166-72
    Abstract     Related articles   

  192. MORENO VILLARES JM
    [Megabladder-microcolon-intestinal hypoperistalsis syndrome]
    An Esp Pediatr 2001; 54: 614-5
    Abstract     Related articles   

  193. LEAHY A, Epstein O
    Non-pharmacological treatments in the irritable bowel syndrome.
    World J Gastroenterol 2001; 7: 313-316
    Abstract     Related articles   

  194. FERRARESE F, De Carne F, Cecere V, Massa ST, Bonadies E
    [Acute colonic pseudoobstruction: physiopathology and treatment]
    G Chir 2001; 22: 238-42
    Abstract     Related articles   

  195. VAN DER SPOEL JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF
    Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure--a prospective, double-blind, placebo-controlled trial.
    Intensive Care Med 2001; 27: 822-7
    Abstract     Related articles   

  196. WALKER AF, Middleton RW, Petrowicz O
    Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study.
    Phytother Res 2001; 15: 58-61
    Abstract     Related articles   

  197. AHN J, Ehrenpreis ED
    Emerging treatments for irritable bowel syndrome.
    Expert Opin Pharmacother 2001; 3: 9-21
    Abstract     Related articles   

  198. GOSAKOVA EV, Derevnina NA, Gontar’ EV, Sorokina EI, Serebriakov SN
    [Status of the immune system in irritable bowel syndrome patients and effect on interference currents]
    Vopr Kurortol Fizioter Lech Fiz Kult 2001; : 30-3
    Abstract     Related articles   

  199. RAPOPORT SI, Kharaian LV, Kurikov AV, Kolesnikov DB
    [A case of a rare side effects of paxil therapy in a male patient with irritable colon syndrome]
    Klin Med (Mosk) 2001; : 72-3
    Abstract     Related articles   

  200. KAMM MA
    Challenges in functional bowel disease.
    Eur J Surg Suppl 2001; : 24-9
    Abstract     Related articles   


  201. Glaxo Wellcome withdraws irritable bowel syndrome medication.
    FDA Consum 2001; 35: 3
    Abstract     Related articles   

  202. DAL-RE R, Luque A, Guardiola L, Rodriguez F
    Irritable bowel syndrome: attrition rates of patients identified at primary care centers during a 50-week period versus those identified in hospitals in a phase II clinical trial.
    Int J Clin Pharmacol Res 2001; 21: 127-36
    Abstract     Related articles   

  203. GIUNTA R, Marfella MA, Maffei A, Lucivero G
    Herpes zoster infection and Ogilvie’s syndrome in non-Hodgkin’s lymphoma with hypogammaglobulinemia.
    Ann Ital Med Int 2001; 16: 50-3
    Abstract     Related articles   

  204. LYDIARD RB
    Irritable bowel syndrome, anxiety, and depression: what are the links?
    J Clin Psychiatry 2001; 62 Suppl 8: 38-45
    Abstract     Related articles   

  205. MAYER EA, Craske M, Naliboff BD
    Depression, anxiety, and the gastrointestinal system.
    J Clin Psychiatry 2001; 62 Suppl 8: 28-36
    Abstract     Related articles   

  206. BAKER DE
    Tegaserod for the treatment of constipation-predominant irritable bowel syndrome.
    Rev Gastroenterol Disord 2001; 1: 187-98
    Abstract     Related articles   

  207. CAMILLERI M
    Dyspepsia, irritable bowel syndrome, and constipation: review and what’s new.
    Rev Gastroenterol Disord 2001; 1: 2-17
    Abstract     Related articles   

  208. BALLENGER JC, Davidson JR, Lecrubier Y, Nutt DJ, Lydiard RB, Mayer EA
    Consensus statement on depression, anxiety, and functional gastrointestinal disorders.
    J Clin Psychiatry 2001; 62 Suppl 8: 48-51
    Abstract     Related articles   

  209. REX DK, Katz PO
    Report from the ACG. Highlights from the American College of Gastroenterology. 66th Annual Scientific Meeting. October 19-23, 2001, Las Vegas, NV.
    Rev Gastroenterol Disord 2001; 1: 199-205
    Abstract     Related articles   

  210. NIEMELA S
    [Irritable bowel or colitis?]
    Duodecim 2001; 117: 5-6
    Abstract     Related articles   

  211. BLACKINGTON E
    Irritable bowel syndrome: an update on treatment options.
    Adv Nurse Pract 2000; 8: 32-40
    Abstract     Related articles   

  212. MCGAHAN L
    Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.
    Issues Emerg Health Technol 2000; : 1-5
    Abstract     Related articles   

  213. LI J, Liu X, Xie P, et Al
    [The regulation of calcium in the movement of colonic smooth muscle in wrap restraint stress rats]
    Zhonghua Nei Ke Za Zhi 2000; 39: 588-91
    Abstract     Related articles   


  214. Innovative treatments for irritable bowel syndrome featured in new continuing ed program.
    Rep Med Guidel Outcomes Res 2000; 11: 1-2, 5-6
    Abstract     Related articles   

  215. DRUG VL, Bradatan B, Tarasi I, Ciochina AD, Ionescu DL, Filip F et al
    [In Process Citation]
    Rev Med Chir Soc Med Nat Iasi 2000; 104: 43-50
    Abstract     Related articles   

  216. PAN G, Lu S, Ke M, et Al
    [An epidemiologic study of irritable bowel syndrome in Beijing -- A stratified randomized study by clustering sampling]
    Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 26-29
    Abstract     Related articles   

  217. PAN G, Lu S, Ke M, Han S, Guo H, Fang X
    Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.
    Chin Med J (Engl) 2000; : 35-9
    Abstract     Related articles   

  218. PANG H
    [Progress of clinical basic study of acupuncture in the treatment of gastrointestinal diseases]
    Zhongguo Zhong Xi Yi Jie He Za Zhi 1999; 19: 188-91
    Abstract     Related articles   

  219. PAN G, Lu S, Han S
    [A study on the symptoms and diagnostic criteria of irritable bowel syndrome in Chinese]
    Zhonghua Nei Ke Za Zhi 1999; 38: 81-4
    Abstract     Related articles   

  220. PIKKARAINEN P
    [When the abdomen is bloating]
    Duodecim 1999; 115: 895-9
    Abstract     Related articles   

  221. SUMMERS WK
    Bismuth Toxicity Masquerading as Alzheimer’s Dementia.
    J Alzheimers Dis 1998; 1: 57-59
    Abstract     Related articles   

  222. FINDLING R, Frishman W, Javed MT, Heffer S, Brandt L
    Calcium Channel Blockers and the Gastrointestinal Tract.
    Am J Ther 1996; 3: 383-408
    Abstract     Related articles   

  223. SWIATCZAK C, Swiatkowski M, Slominski JB, Jawien A, Kowianski Z, Zasieczny W
    [Duodenogastric reflux in patients with irritable bowel syndrome]
    Pol Tyg Lek 1995; 50: 804-6
    Abstract     Related articles   

  224. KILKENS TO, Honig A, Rozendaal N, Van Nieuwenhoven MA, Brummer RJ
    Serotonergic modulators in the treatment of irritable bowel syndrome - influence on psychiatric and gastrointestinal symptoms.
    Aliment Pharmacol Ther 2003; 17: 43-51.
    Abstract     Related articles   

  225. HU WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC et al
    Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study.
    Aliment Pharmacol Ther 2002; 16: 2081-8
    Abstract     Related articles   

  226. LAMB EJ, Wong T, Smith DJ, Simpson DE, Coakley AJ, Moniz C et al
    Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther 2002; 16: 1895-902
    Abstract     Related articles   

  227. NOVICK J, Miner P, Krause R, Glebas K, Bliesath H, Ligozio G et al
    A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.
    Aliment Pharmacol Ther 2002; 16: 1877-88
    Abstract     Related articles   

  228. TOUGAS G, Snape WJ, Otten MH, Earnest DL, Langaker KE, Pruitt RE et al
    Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther 2002; 16: 1701-8
    Abstract     Related articles   

  229. HAWKES ND, Rhodes J, Evans BK, Rhodes P, Hawthorne AB, Thomas GA
    Naloxone treatment for irritable bowel syndrome - a randomized controlled trial with an oral formulation.
    Aliment Pharmacol Ther 2002; 16: 1649-1654
    Abstract     Related articles   

  230. CAMILLERI M, Heading RC, Thompson WG
    Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.
    Aliment Pharmacol Ther 2002; 16: 1407-30
    Abstract     Related articles   

  231. THOMPSON WG
    The treatment of irritable bowel syndrome.
    Aliment Pharmacol Ther 2002; 16: 1395-406
    Abstract     Related articles   

  232. MAYER EA, Berman S, Derbyshire SW, Suyenobu B, Chang L, Fitzgerald L et al
    The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients.
    Aliment Pharmacol Ther 2002; 16: 1357-66
    Abstract     Related articles   

  233. MITCHELL SA, Mee AS, Smith GD, Palmer KR, Chapman RW
    Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.
    Aliment Pharmacol Ther 2002; 16: 1187-95
    Abstract     Related articles   

  234. EL-SERAG HB, Olden K, Bjorkman D
    Health-related quality of life among persons with irritable bowel syndrome: a systematic review.
    Aliment Pharmacol Ther 2002; 16: 1171-1185
    Abstract     Related articles   

  235. BORTOLOTTI M, Coccia G, Grossi G, Miglioli M
    The treatment of functional dyspepsia with red pepper.
    Aliment Pharmacol Ther 2002; 16: 1075-82
    Abstract     Related articles   

  236. CLEMENS CH, Samsom M, Van Berge Henegouwen GP, Fabri M, Smout AJ
    Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers.
    Aliment Pharmacol Ther 2002; 16: 993-1002
    Abstract     Related articles   

  237. SVEDBERG P, Johansson S, Wallander MA, Hamelin B, Pedersen NL
    Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study.
    Aliment Pharmacol Ther 2002; 16: 975-983
    Abstract     Related articles   

  238. KAMM MA
    The complexity of drug development for irritable bowel syndrome.
    Aliment Pharmacol Ther 2002; 16: 343-51
    Abstract     Related articles   

  239. DE PONTI F, De Giorgio R
    The cathartic colon?
    Aliment Pharmacol Ther 2002; 16: 643-4
    Abstract     Related articles   

  240. DE GIORGIO R, Barbara G, Stanghellini V, Tonini M, Vasina V, Cola B et al
    Review article: the pharmacological treatment of acute colonic pseudo- obstruction.
    Aliment Pharmacol Ther 2001; 15: 1717-27
    Abstract     Related articles   

  241. VIERA AJ, Hoag S, Shaughnessy J
    Management of irritable bowel syndrome.
    Am Fam Physician 2002; 66: 1867-74, 1856.
    Abstract     Related articles   


  242. Information from your family doctor. IBS--what you need to know.
    Am Fam Physician 2002; 66: 1880.
    Abstract     Related articles   

  243. CRAIG T, Kakumanu S
    Chronic fatigue syndrome: evaluation and treatment.
    Am Fam Physician 2002; 65: 1083-90
    Abstract     Related articles   

  244. THOMPSON JJ, Elsenbruch S, Harnish MJ, Orr WC
    Autonomic functioning during REM sleep differentiates IBS symptom subgroups.
    Am J Gastroenterol 2002; 97: 3147-53.
    Abstract     Related articles   

  245. OLDEN K, DeGarmo RG, Jhingran P, Bagby B, Decker C, Markowitz M et al
    Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 3139-46.
    Abstract     Related articles   

  246. SACH J, Bolus R, Fitzgerald L, Naliboff BD, Chang L, Mayer EA
    Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
    Am J Gastroenterol 2002; 97: 3131-8.
    Abstract     Related articles   

  247. BRANDT LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W et al
    Systematic review on the management of irritable bowel syndrome in North America.
    Am J Gastroenterol 2002; 97: S7-26
    Abstract     Related articles   


  248. Evidence-based position statement on the management of irritable bowel syndrome in North America.
    Am J Gastroenterol 2002; 97: S1-5
    Abstract     Related articles   

  249. CASH BD, Schoenfeld P, Chey WD
    The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review.
    Am J Gastroenterol 2002; 97: 2812-9
    Abstract     Related articles   

  250. CHEY WD, Olden K, Carter E, Boyle J, Drossman D, Chang L
    Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women.
    Am J Gastroenterol 2002; 97: 2803-11
    Abstract     Related articles   

  251. BERMAN SM, Naliboff BD, Chang L, Fitzgerald L, Antolin T, Camplone A et al
    Enhanced preattentive central nervous system reactivity in irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 2791-7
    Abstract     Related articles   

  252. STANGHELLINI V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R et al
    Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 2738-43
    Abstract     Related articles   

  253. PIMENTEL M
    Do antibiotics influence IBS?
    Am J Gastroenterol 2002; 97: 2681
    Abstract     Related articles   

  254. MORGANROTH J, Ruegg PC, Dunger-Baldauf C, Appel-Dingemanse S, Bliesath H, Lefkowitz M
    Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Am J Gastroenterol 2002; 97: 2321-7
    Abstract     Related articles   

  255. HEBDEN JM, Blackshaw E, D’Amato M, Perkins AC, Spiller RC
    Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.
    Am J Gastroenterol 2002; 97: 2315-20
    Abstract     Related articles   

  256. ELSENBRUCH S, Thompson JJ, Hamish MJ, Exton MS, Orr WC
    Behavioral and physiological sleep characteristics in women with irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 2306-14
    Abstract     Related articles   

  257. ABDULKARIM AS, Burgart LJ, See J, Murray JA
    Etiology of nonresponsive celiac disease: results of a systematic approach.
    Am J Gastroenterol 2002; 97: 2016-21
    Abstract     Related articles   

  258. NEURATH MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A et al
    Noninvasive assessment of Crohn’s disease activity: a comparison of 18F- fluorodeoxyglucose positron emission tomography, hydromagne
    Am J Gastroenterol 2002; 97: 1978-85
    Abstract     Related articles   

  259. SAITO YA, Schoenfeld P, Locke GR 3rd
    The epidemiology of irritable bowel syndrome in North America: a systematic review.
    Am J Gastroenterol 2002; 97: 1910-5
    Abstract     Related articles   

  260. PATA C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O
    Serotonin transporter gene polymorphism in irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 1780-4
    Abstract     Related articles   

  261. O’LEARY C, Wieneke P, Buckley S, O’Regan P, Cronin CC, Quigley EM et al
    Celiac disease and irritable bowel-type symptoms.
    Am J Gastroenterol 2002; 97: 1463-7
    Abstract     Related articles   

  262. FIDELHOLTZ J, Smith W, Rawls J, Shi Y, Zack A, Ruegg P et al
    Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms.
    Am J Gastroenterol 2002; 97: 1176-81
    Abstract     Related articles   

  263. SHEN B, Achkar JP, Lashner BA, Ormsby AH, Brzezinski A, Soffer EE et al
    Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.
    Am J Gastroenterol 2002; 97: 972-7
    Abstract     Related articles   

  264. GROLL D, Vanner SJ, Depew WT, DaCosta LR, Simon JB, Groll A et al
    The IBS-36: a new quality of life measure for irritable bowel syndrome.
    Am J Gastroenterol 2002; 97: 962-71
    Abstract     Related articles   

  265. GONSALKORALE WM, Houghton LA, Whorwell PJ
    Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.
    Am J Gastroenterol 2002; 97: 954-61
    Abstract     Related articles   

  266. BONAZ B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF et al
    Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study.
    Am J Gastroenterol 2002; 97: 654-61
    Abstract     Related articles   

  267. SIMREN M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES
    Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Am J Gastroenterol 2002; 97: 389-96
    Abstract     Related articles   

  268. BERNSTEIN CN, Frankenstein UN, Rawsthorne P, Pitz M, Summers R, McIntyre MC
    Cortical mapping of visceral pain in patients with GI disorders using functional magnetic resonance imaging.
    Am J Gastroenterol 2002; 97: 319-27
    Abstract     Related articles   

  269. CHEVALLIER P, Marcy PY, Francois E, Peten EP, Motamedi JP, Padovani B et al
    Controlled transperitoneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie’s syndrome.
    Am J Gastroenterol 2002; 97: 471-4
    Abstract     Related articles   

  270. MAXWELL PR, Rink E, Kumar D, Mendall MA
    Antibiotics increase functional abdominal symptoms.
    Am J Gastroenterol 2002; 97: 104-8
    Abstract     Related articles   

  271. CHANG L, Lee OY, Naliboff B, Schmulson M, Mayer EA
    Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome.
    Am J Gastroenterol 2001; 96: 3341-7
    Abstract     Related articles   

  272. PIRLICH M, Lochs H, Schmidt HH
    Liver cirrhosis in erythropoietic protoporphyria: improvement of liver function with ursodeoxycholic acid.
    Am J Gastroenterol 2001; 96: 3468-9
    Abstract     Related articles   

  273. RAINE R, Haines A, Sensky T, Hutchings A, Larkin K, Black N
    Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?
    BMJ 2002; 325: 1082.
    Abstract     Related articles   

  274. LIEVRE M
    Alosetron for irritable bowel syndrome.
    BMJ 2002; 325: 555-6
    Abstract     Related articles   

  275. MOYNIHAN R
    Alosetron: a case study in regulatory capture, or a victory for patients’ rights?
    BMJ 2002; 325: 592-5
    Abstract     Related articles   

  276. MOYNIHAN R
    FDA advisers warn of more deaths if drug is relaunched.
    BMJ 2002; 325: 561
    Abstract     Related articles   

  277. CHARATAN F
    FDA advisory panels recommend Lotronex be put back on market.
    BMJ 2002; 324: 1053
    Abstract     Related articles   

  278. MOYNIHAN R, Heath I, Henry D
    Selling sickness: the pharmaceutical industry and disease mongering.
    BMJ 2002; 324: 886-91
    Abstract     Related articles   

  279. SPILLER RC
    ABC of the upper gastrointestinal tract: Anorexia, nausea, vomiting, and pain.
    BMJ 2001; 323: 1354-7
    Abstract     Related articles   

  280. KEEFER L, Blanchard EB
    A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome.
    Behav Res Ther 2002; 40: 541-6
    Abstract     Related articles   

  281. BLANCHARD EB, Keefer L, Payne A, Turner SM, Galovski TE
    Early abuse, psychiatric diagnoses and irritable bowel syndrome.
    Behav Res Ther 2002; 40: 289-98
    Abstract     Related articles   

  282. ILNYCKYJ A, Bernstein CN
    Sexual abuse in irritable bowel syndrome: To ask or not to ask - That is the question.
    Can J Gastroenterol 2002; 16: 801-5
    Abstract     Related articles   

  283. FERRAZZI S, Thompson GW, Irvine EJ, Pare P, Rance L
    Diagnosis of constipation in family practice.
    Can J Gastroenterol 2002; 16: 159-64
    Abstract     Related articles   

  284. HUERTA I, Valdovinos MA, Schmulson M
    Irritable bowel syndrome in Mexico.
    Dig Dis 2001; 19: 251-7
    Abstract     Related articles   

  285. VILLANUEVA A, Dominguez-Munoz JE, Mearin F
    Update in the therapeutic management of irritable bowel syndrome.
    Dig Dis 2001; 19: 244-50
    Abstract     Related articles   

  286. MAYER EA, Naliboff BD, Chang L
    Basic pathophysiologic mechanisms in irritable bowel syndrome.
    Dig Dis 2001; 19: 212-8
    Abstract     Related articles   

  287. MONNIKES H, Tebbe JJ, Hildebrandt M, Arck P, Osmanoglou E, Rose M et al
    Role of Stress in Functional Gastrointestinal Disorders. evidence for stress-induced alterations in gastrointestinal motility and sensitivity.
    Dig Dis 2001; 19: 201-11
    Abstract     Related articles   

  288. VAIRA D, Gatta L, Ricci C, D’Anna L, Miglioli M
    How valuable is the application on consensus guidelines in the management of functional gastrointestinal disorders?
    Dig Dis 2001; 19: 225-31
    Abstract     Related articles   

  289. GSCHOSSMANN JM, Haag S, Holtmann G
    Epidemiological trends of functional gastrointestinal disorders.
    Dig Dis 2001; 19: 189-94
    Abstract     Related articles   

  290. LAU EM, Chan FK, Ziea ET, Chan CS, Wu JC, Sung JJ
    Epidemiology of irritable bowel syndrome in Chinese.
    Dig Dis Sci 2002; 47: 2621-4
    Abstract     Related articles   

  291. SEN S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO
    Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
    Dig Dis Sci 2002; 47: 2615-20
    Abstract     Related articles   

  292. PALSSON OS, Turner MJ, Johnson DA, Burnelt CK, Whitehead WE
    Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms.
    Dig Dis Sci 2002; 47: 2605-14
    Abstract     Related articles   

  293. BUBENIK GA
    Gastrointestinal melatonin: localization, function, and clinical relevance.
    Dig Dis Sci 2002; 47: 2336-48
    Abstract     Related articles   

  294. MOUSA H, Hyman PE, Cocjin J, Flores AF, Di Lorenzo C
    Long-term outcome of congenital intestinal pseudoobstruction.
    Dig Dis Sci 2002; 47: 2298-305
    Abstract     Related articles   

  295. GUPTA V, Sheffield D, Verne GN
    Evidence for autonomic dysregulation in the irritable bowel syndrome.
    Dig Dis Sci 2002; 47: 1716-22
    Abstract     Related articles   

  296. SHIH YC, Barghout VE, Sandler RS, Jhingran P, Sasane M, Cook S et al
    Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.
    Dig Dis Sci 2002; 47: 1705-15
    Abstract     Related articles   

  297. PARISI GC, Zilli M, Miani MP, Carrara M, Bottona E, Verdianelli G et al
    High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).
    Dig Dis Sci 2002; 47: 1697-704
    Abstract     Related articles   

  298. CRAINE BL, Silpa ML, O’Toole CJ
    Two-dimensional positional mapping of gastrointestinal sounds in control and functional bowel syndrome patients.
    Dig Dis Sci 2002; 47: 1290-6
    Abstract     Related articles   

  299. POITRAS MR, Verrier P, So C, Paquet S, Bouin M, Poitras P
    Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life.
    Dig Dis Sci 2002; 47: 1297-307
    Abstract     Related articles   

  300. HOLLOWELL J, Lundgren A, Johansson S
    Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.
    Dig Dis Sci 2002; 47: 1115-21
    Abstract     Related articles   

  301. POITRAS P, Riberdy Poitras M, Plourde V, Boivin M, Verrier P
    Evolution of visceral sensitivity in patients with irritable bowel syndrome.
    Dig Dis Sci 2002; 47: 914-20
    Abstract     Related articles   

  302. COLE SJ, Duncan HD, Claydon AH, Austin D, Bowling TE, Silk DB
    Distal colonic motor activity in four subgroups of patients with irritable bowel syndrome.
    Dig Dis Sci 2002; 47: 345-55
    Abstract     Related articles   

  303. BORUM ML
    Physician perception of IBS management in women and men.
    Dig Dis Sci 2002; 47: 236-7
    Abstract     Related articles   

  304. THOMPSON WG, Irvine EJ, Pare P, Ferrazzi S, Rance L
    Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.
    Dig Dis Sci 2002; 47: 225-35
    Abstract     Related articles   

  305. BERGERON RJ, Wiegand J, Fannin TL
    Control of irritable bowel syndrome with polyamine analogs: a structure- activity study.
    Dig Dis Sci 2001; 46: 2615-23
    Abstract     Related articles   

  306. THOMSON AB, Keelan M, Thiesen A, Clandinin MT, Ropeleski M, Wild GE
    Small bowel review: normal physiology part 2.
    Dig Dis Sci 2001; 46: 2588-607
    Abstract     Related articles   

  307. FERNANDEZ-BANARES F, Esteve M, Salas A, Forne TM, Espinos JC, Martin-Comin J et al
    Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea.
    Dig Dis Sci 2001; 46: 2231-8
    Abstract     Related articles   

  308. SALLON S, Ben-Arye E, Davidson R, Shapiro H, Ginsberg G, Ligumsky M
    A novel treatment for constipation-predominant irritable bowel syndrome using padma((r))lax, a tibetan herbal formula.
    Digestion 2002; 65: 161-71
    Abstract     Related articles   

  309. COREMANS G, Azpiroz F, Collins S, Dapoigny M, Muller-Lissner SA, Pace F et al
    The rectum: a window to irritable bowel syndrome?
    Digestion 2002; 65: 238-49
    Abstract     Related articles   

  310. MULLER-LISSNER SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK et al
    Epidemiological aspects of irritable bowel syndrome in europe and north america.
    Digestion 2001; 64: 200-4
    Abstract     Related articles   

  311. GLENDE M, Morselli-Labate AM, Battaglia G, Evangelista S
    Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Eur J Gastroenterol Hepatol 2002; 14: 1331-8
    Abstract     Related articles   

  312. MULLER-LISSNER SA, Pirk O
    Irritable bowel syndrome in Germany. A cost of illness study.
    Eur J Gastroenterol Hepatol 2002; 14: 1325-9
    Abstract     Related articles   

  313. PARRY SD, Barton JR, Welfare MR
    Is lactose intolerance implicated in the development of post-infectious irritable bowel syndrome or functional diarrhoea in previously asymptomatic people?
    Eur J Gastroenterol Hepatol 2002; 14: 1225-30
    Abstract     Related articles   

  314. SUMMERTON CB, Longlands MG, Wiener K, Shreeve DR
    Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Eur J Gastroenterol Hepatol 2002; 14: 841-5
    Abstract     Related articles   

  315. SEN S, Dear KL, King TS, Elia M, Hunter JO
    Evaluation of hydrogen excretion after lactulose administration as a screening test for causes of irritable bowel syndrome.
    Eur J Gastroenterol Hepatol 2002; 14: 753-6
    Abstract     Related articles   

  316. POULLIS AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A et al
    A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders.
    Eur J Gastroenterol Hepatol 2002; 14: 409-12
    Abstract     Related articles   

  317. PICHE T, Collins SM, Rampal P
    [Role of enteric infections and inflammation in functional bowel disorders]
    Gastroenterol Clin Biol 2002; 26: 624-9
    Abstract     Related articles   

  318. CELLIER C
    [Is irritable bowel syndrome a latent form of celiac disease?]
    Gastroenterol Clin Biol 2002; 26: 341-2
    Abstract     Related articles   

  319. COFFIN B
    [Colonic microflora and motility. Physiological data and during irritable bowel syndrome]
    Gastroenterol Clin Biol 2001; 25 Spec No 2: C85-8
    Abstract     Related articles   

  320. CHASSANY O, Bergmann JF
    [Functional intestinal disorders and quality of life]
    Gastroenterol Clin Biol 2001; 25 Spec No 2: C54-62
    Abstract     Related articles   

  321. DELVAUX M, Frexinos J
    [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives]
    Gastroenterol Clin Biol 2001; 25 Spec No 2: C42-53
    Abstract     Related articles   

  322. FIORAMONTI J, Bueno L, Delvaux M, Frexinos J
    [Old and new physiopathological concepts of irritable bowel syndrome]
    Gastroenterol Clin Biol 2001; 25 Spec No 2: C34-41
    Abstract     Related articles   

  323. HEITKEMPER M, Carter E, Ameen V, Olden K, Cheng L
    Women with irritable bowel syndrome: differences in patients’ and physicians’ perceptions.
    Gastroenterol Nurs 2002; 25: 192-200
    Abstract     Related articles   

  324. DIPALMA AM, DiPalma JA
    Women’s colonic digestive health.
    Gastroenterol Nurs 2002; 25: 3-8
    Abstract     Related articles   

  325. YU M
    M2A capsule endoscopy. A breakthrough diagnostic tool for small intestine imaging.
    Gastroenterol Nurs 2002; 25: 24-7
    Abstract     Related articles   

  326. HEITKEMPER M, Olden K, Gordon S, Carter E, Chang L
    Irritable bowel syndrome. A survey of nurses’ knowledge.
    Gastroenterol Nurs 2001; 24: 281-7
    Abstract     Related articles   

  327. JARRETT M, Visser R, Heitkemper M
    Diet triggers symptoms in women with irritable bowel syndrome. The patient’s perspective.
    Gastroenterol Nurs 2001; 24: 246-52
    Abstract     Related articles   

  328. LUSTYK MK, Jarrett ME, Bennett JC, Heitkemper MM
    Does a physically active lifestyle improve symptoms in women with irritable bowel syndrome?
    Gastroenterol Nurs 2001; 24: 129-37
    Abstract     Related articles   

  329. HEITKEMPER M, Jarrett M
    Irritable bowel syndrome: causes and treatment.
    Gastroenterol Nurs 2000; 23: 256-63
    Abstract     Related articles   

  330. DROSSMAN DA, Camilleri M, Mayer EA, Whitehead WE
    AGA technical review on irritable bowel syndrome.
    Gastroenterology 2002; 123: 2108-2131
    Abstract     Related articles   


  331. American Gastroenterological Association medical position statement: Irritable bowel syndrome.
    Gastroenterology 2002; 123: 2105-2107
    Abstract     Related articles   

  332. TORNBLOM H, Lindberg G, Nyberg B, Veress B
    Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome.
    Gastroenterology 2002; 123: 1972-9
    Abstract     Related articles   

  333. CALVERT EL, Houghton LA, Cooper P, Morris J, Whorwell PJ
    Long-term improvement in functional dyspepsia using hypnotherapy.
    Gastroenterology 2002; 123: 1778-85
    Abstract     Related articles   

  334. CHANG L, Heitkemper MM
    Gender differences in irritable bowel syndrome.
    Gastroenterology 2002; 123: 1686-1701
    Abstract     Related articles   

  335. SANDERS DS
    There is a relationship between celiac disease and patients with symptoms of irritable bowel syndrome.
    Gastroenterology 2002; 123: 1408
    Abstract     Related articles   

  336. BERMAN SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L et al
    Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron.
    Gastroenterology 2002; 123: 969-977
    Abstract     Related articles   

  337. CALDARELLA MP, Balatsinou C, Milano A, Laterza F, Neri M
    There is a relationship between celiac disease and patients with symptoms of irritable bowel syndrome.
    Gastroenterology 2002; 123: 1408-9
    Abstract     Related articles   

  338. SERRA J, Salvioli B, Azpiroz F, Malagelada JR
    Lipid-induced intestinal gas retention in irritable bowel syndrome.
    Gastroenterology 2002; 123: 700-6
    Abstract     Related articles   

  339. CAMILLERI M, Delgado-Aros S
    Much to do about gas.
    Gastroenterology 2002; 123: 933-5
    Abstract     Related articles   

  340. TIBBLE JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I
    Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.
    Gastroenterology 2002; 123: 450-60
    Abstract     Related articles   

  341. CAMILLERI M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE et al
    Serotonin-transporter polymorphism pharmacogenetics in diarrhea- predominant irritable bowel syndrome.
    Gastroenterology 2002; 123: 425-32
    Abstract     Related articles   

  342. COLLINS SM
    A case for an immunological basis for irritable bowel syndrome.
    Gastroenterology 2002; 122: 2078-80
    Abstract     Related articles   

  343. MAYER EA, Collins SM
    Evolving pathophysiologic models of functional gastrointestinal disorders.
    Gastroenterology 2002; 122: 2032-48
    Abstract     Related articles   

  344. CHADWICK VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A et al
    Activation of the mucosal immune system in irritable bowel syndrome.
    Gastroenterology 2002; 122: 1778-83
    Abstract     Related articles   

  345. BOUIN M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M et al
    Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds.
    Gastroenterology 2002; 122: 1771-7
    Abstract     Related articles   

  346. CALDARELLA MP, Serra J, Azpiroz F, Malagelada JR
    Prokinetic effects in patients with intestinal gas retention.
    Gastroenterology 2002; 122: 1748-55
    Abstract     Related articles   

  347. HASLER WL
    Celiac sprue as a possible cause of symptoms in presumed irritable bowel syndrome.
    Gastroenterology 2002; 122: 2086-7
    Abstract     Related articles   

  348. SANDLER RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C et al
    The burden of selected digestive diseases in the United States.
    Gastroenterology 2002; 122: 1500-1511
    Abstract     Related articles   

  349. OLDEN KW
    Diagnosis of irritable bowel syndrome.
    Gastroenterology 2002; 122: 1701-14
    Abstract     Related articles   

  350. WHITEHEAD WE, Palsson O, Jones KR
    Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
    Gastroenterology 2002; 122: 1140-56
    Abstract     Related articles   

  351. HASLER WL
    Air apparent: studies of gas and bloating in IBS.
    Gastroenterology 2002; 122: 576-7
    Abstract     Related articles   

  352. DE GIACOMO C
    Management of irritable bowel syndrome.
    Gastroenterology 2001; 121: 1527-8
    Abstract     Related articles   

  353. GONSALKORALE WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV
    Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?
    Gut 2003; 52: 91-3.
    Abstract     Related articles   

  354. HOUGHTON LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ
    Visceral sensation and emotion: a study using hypnosis.
    Gut 2002; 51: 701-4
    Abstract     Related articles   

  355. NEAL KR, Barker L, Spiller RC
    Prognosis in post-infective irritable bowel syndrome: a six year follow up study.
    Gut 2002; 51: 410-3
    Abstract     Related articles   

  356. LEA R, Whorwell PJ
    Infection and irritability.
    Gut 2002; 51: 305-6
    Abstract     Related articles   

  357. FIORAMONTI J, Bueno L
    Centrally acting agents and visceral sensitivity.
    Gut 2002; 51 Suppl 1: I91-I95
    Abstract     Related articles   

  358. SPILLER R
    Pharmacotherapy: non-serotonergic mechanisms.
    Gut 2002; 51 Suppl 1: I87-I90
    Abstract     Related articles   

  359. CAMILLERI M
    Serotonergic modulation of visceral sensation: lower gut.
    Gut 2002; 51 Suppl 1: I81-I86
    Abstract     Related articles   

  360. DELVAUX M
    Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.
    Gut 2002; 51 Suppl 1: I67-I71
    Abstract     Related articles   

  361. BARBARA G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R
    A role for inflammation in irritable bowel syndrome?
    Gut 2002; 51 Suppl 1: I41-I44
    Abstract     Related articles   

  362. CAMILLERI M
    Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.
    Gut 2002; 51 Suppl 1: I34-I40
    Abstract     Related articles   

  363. MERTZ H
    Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.
    Gut 2002; 51 Suppl 1: I29-I33
    Abstract     Related articles   

  364. VAN DEVENTER SJ
    A place for TACE.
    Gut 2002; 51: 5-6
    Abstract     Related articles   

  365. MALAGELADA JR
    Sensation and gas dynamics in functional gastrointestinal disorders.
    Gut 2002; 51 Suppl 1: i72-5
    Abstract     Related articles   

  366. BEGLINGER C, Degen L
    Role of thyrotrophin releasing hormone and corticotrophin releasing factor in stress related alterations of gastrointestinal motor function.
    Gut 2002; 51 Suppl 1: i45-9
    Abstract     Related articles   

  367. AZPIROZ F
    Hypersensitivity in functional gastrointestinal disorders.
    Gut 2002; 51 Suppl 1: i25-8
    Abstract     Related articles   

  368. BUENO L, Fioramonti J
    Visceral perception: inflammatory and non-inflammatory mediators.
    Gut 2002; 51 Suppl 1: i19-23
    Abstract     Related articles   

  369. HOUGHTON LA, Lea R, Jackson N, Whorwell PJ
    The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers.
    Gut 2002; 50: 471-4
    Abstract     Related articles   

  370. BRADESI S, Eutamene H, Fioramonti J, Bueno L
    Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids.
    Gut 2002; 50: 349-54
    Abstract     Related articles   

  371. BARDOU M, Montembault S, Giraud V, Balian A, Borotto E, Houdayer C et al
    Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study.
    Gut 2002; 50: 38-42
    Abstract     Related articles   

  372. AGARWAL MK, Bhatia SJ, Desai SA, Bhure U, Melgiri S
    Effect of red chillies on small bowel and colonic transit and rectal sensitivity in men with irritable bowel syndrome.
    Indian J Gastroenterol 2002; 21: 179-82
    Abstract     Related articles   

  373. RODRIGUES G, Kannaiyan L, Gopasetty M, Rao S, Shenoy R
    Colonic pseudo-obstruction due to herpes zoster.
    Indian J Gastroenterol 2002; 21: 203-4
    Abstract     Related articles   

  374. KAUSHIK A, Pursnani ML, Kar P
    Multicenter phase III clinical trial of otilonium bromide in irritable bowel syndrome.
    Indian J Gastroenterol 2002; 21: 85-6
    Abstract     Related articles   

  375. PALMER BV, Lockley WJ, Palmer RB, Kulinskaya E
    Improvement in irritable bowel syndrome following ano-rectal surgery.
    Int J Colorectal Dis 2002; 17: 402-11
    Abstract     Related articles   

  376. PATEL RP, Petitta A, Fogel R, Peterson E, Zarowitz BJ
    The economic impact of irritable bowel syndrome in a managed care setting.
    J Clin Gastroenterol 2002; 35: 14-20
    Abstract     Related articles   

  377. RINGEL Y, Drossman DA
    Irritable bowel syndrome: classification and conceptualization.
    J Clin Gastroenterol 2002; 35: S7-10
    Abstract     Related articles   

  378. CALLAHAN MJ
    Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.
    J Clin Gastroenterol 2002; 35: S58-67
    Abstract     Related articles   

  379. WALD A
    Psychotropic agents in irritable bowel syndrome.
    J Clin Gastroenterol 2002; 35: S53-7
    Abstract     Related articles   

  380. FLOCH MH, Narayan R
    Diet in the irritable bowel syndrome.
    J Clin Gastroenterol 2002; 35: S45-52
    Abstract     Related articles   

  381. ROSEMORE JG, Lacy BE
    Irritable bowel syndrome: basis of clinical management strategies.
    J Clin Gastroenterol 2002; 35: S37-44
    Abstract     Related articles   

  382. LEMBO TJ, Fink RN
    Clinical assessment of irritable bowel syndrome.
    J Clin Gastroenterol 2002; 35: S31-6
    Abstract     Related articles   

  383. TOUGAS G
    The nature of pain in irritable bowel syndrome.
    J Clin Gastroenterol 2002; 35: S26-30
    Abstract     Related articles   

  384. RINGEL Y
    Brain research in functional gastrointestinal disorders.
    J Clin Gastroenterol 2002; 35: S23-5
    Abstract     Related articles   

  385. HUNT RH
    Evolving concepts in the pathophysiology of functional gastrointestinal disorder.
    J Clin Gastroenterol 2002; 35: S2-6
    Abstract     Related articles   

  386. WOOD JD
    Neuropathophysiology of irritable bowel syndrome.
    J Clin Gastroenterol 2002; 35: S11-22
    Abstract     Related articles   

  387. PIMENTEL M, Rossi F, Chow EJ, Ofman J, Fullerton S, Hassard P et al
    Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux.
    J Clin Gastroenterol 2002; 34: 221-4
    Abstract     Related articles   

  388. LACY BE, Yu S
    Tegaserod: A New 5-HT4 Agonist.
    J Clin Gastroenterol 2002; 34: 27-33
    Abstract     Related articles   

  389. SHEIKH RA, Yasmeen S, Pauly MP, Trudeau WL
    Pseudomembranous colitis without diarrhea presenting clinically as acute intestinal pseudo-obstruction.
    J Gastroenterol 2001; 36: 629-32
    Abstract     Related articles   

  390. BOEY CC, Goh KL
    Psychosocial factors and childhood recurrent abdominal pain.
    J Gastroenterol Hepatol 2002; 17: 1250-1253
    Abstract     Related articles   

  391. KWAN AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H
    Prevalence of irritable bowel syndrome in Hong Kong.
    J Gastroenterol Hepatol 2002; 17: 1180-6
    Abstract     Related articles   

  392. KELLOW JE
    Advances in the management of irritable bowel syndrome.
    J Gastroenterol Hepatol 2002; 17: 503-7
    Abstract     Related articles   

  393. GLISE H, Wiklund I
    Health-related quality of life and gastrointestinal disease.
    J Gastroenterol Hepatol 2002; 17 Suppl 1: 72-84
    Abstract     Related articles   

  394. EDWARDS JT, Radford-Smith GL, Florin TH
    Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics.
    J Gastroenterol Hepatol 2001; 16: 1235-8
    Abstract     Related articles   

  395. DI LORENZO C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A
    Visceral hyperalgesia in children with functional abdominal pain.
    J Pediatr 2001; 139: 838-843
    Abstract     Related articles   

  396. CRANE C, Martin M
    Perceived vulnerability to illness in individuals with irritable bowel syndrome.
    J Psychosom Res 2002; 53: 1115-1122.
    Abstract     Related articles   

  397. LACHENMEYER J, Deucher RS
    Cognitive-behavioral treatment of irritable bowel syndrome. by B.B. Toner, Z.V. Segal, S.D. Emmont and D. Myran, New York: Guilford Press, 2000.
    J Psychosom Res 2001; 51: 767
    Abstract     Related articles   

  398. TALLEY N, Spiller R
    Irritable bowel syndrome: a little understood organic bowel disease?
    Lancet 2002; 360: 555
    Abstract     Related articles   

  399. MCCARTHY M
    FDA allows controversial bowel drug back on to market.
    Lancet 2002; 359: 2095
    Abstract     Related articles   

  400. MCCARTHY M
    FDA recommends bringing controversial IBS drug back.
    Lancet 2002; 359: 1491-2
    Abstract     Related articles   

  401. SANDERS D
    Irritable bowel syndrome and coeliac disease.
    Lancet 2002; 359: 1436-7
    Abstract     Related articles   

  402. TURSI A
    Irritable bowel syndrome and coeliac disease.
    Lancet 2002; 359: 1347
    Abstract     Related articles   

  403. THOMPSON WG
    Irritable bowel syndrome and coeliac disease.
    Lancet 2002; 359: 1346
    Abstract     Related articles   

  404. HIN H
    Irritable bowel syndrome and coeliac disease.
    Lancet 2002; 359: 1346
    Abstract     Related articles   

  405. TALLEY NJ
    Serotoninergic neuroenteric modulators.
    Lancet 2001; 358: 2061-8
    Abstract     Related articles   

  406. MORGAN T, Robson KM
    Irritable bowel syndrome. Diagnosis is based on clinical criteria.
    Postgrad Med 2002; 112: 30-2, 35-6, 39-41
    Abstract     Related articles   

  407. SOSLAND MD
    Cognitive-behavioral treatment of irritable bowel syndrome: the brain- gut connection.
    Psychosomatics 2002; 43: 511-2
    Abstract     Related articles   

  408. SAGDUYU K
    Peppermint oil for irritable bowel syndrome.
    Psychosomatics 2002; 43: 508-9
    Abstract     Related articles   

  409. MASAND PS, Gupta S, Schwartz TL, Kaplan D, Virk S, Hameed A et al
    Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?
    Psychosomatics 2002; 43: 451-5
    Abstract     Related articles   

  410. HOBBIS IC, Turpin G, Read NW
    A re-examination of the relationship between abuse experience and functional bowel disorders.
    Scand J Gastroenterol 2002; 37: 423-30
    Abstract     Related articles   

  411. ROSSEL P, Pedersen P, Niddam D, Arendt-Nielsen L, Chen AC, Drewes AM
    Cerebral response to electric stimulation of the colon and abdominal skin in healthy subjects and patients with irritable bowel syndrome.
    Scand J Gastroenterol 2001; 36: 1259-66
    Abstract     Related articles   

  412. READ NW
    IBS--it all depends where you draw the line.
    Scand J Gastroenterol 2001; 36: 1121-2
    Abstract     Related articles   

Thank you for your interest in scientific medicine.


Thank you for your interest in scientific medicine.


Design:


;